Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jan;26(1):38-47.
doi: 10.1111/hdi.12971. Epub 2021 Jul 8.

Predialysis serum phosphate and intradialytic hypotension

Katherine Scovner Ravi  1   2 , Patrick B Reeves  3 , Simon Correa  1   2 , João Sérgio Neves  4   5 , Sushrut S Waikar  6 , Suraj S Mothi  1   2 , Finnian R Mc Causland  1   2
Affiliations
Randomized Controlled Trial

Predialysis serum phosphate and intradialytic hypotension

Katherine Scovner Ravi et al. Hemodial Int. 2022 Jan.

Abstract

Introduction: Intradialytic hypotension (IDH) is a common complication of hemodialysis (HD) and is associated with excess morbidity and mortality. Higher serum phosphate is associated with adverse cardiovascular outcomes in maintenance HD patients; however, its association with IDH has not previously been assessed.

Methods: This is an analysis of a prospective cohort of 969 HD patients (80,968 HD sessions) receiving HD at a large dialysis organization (LDO) and a post-hoc analysis of 1838 HD patients (10,594 HD sessions) in the Hemodialysis study (HEMO), a multicenter randomized controlled trial that examined standard or high-dose HD and low-flux or high-flux membranes. Unadjusted and adjusted mixed effects regression models were fit to determine the association of pre-HD serum phosphate with IDH, defined as a nadir intra-HD systolic blood pressure (SBP) <90 mmHg.

Findings: In the LDO cohort, baseline mean pre-HD serum phosphate was 5.2 ± 1.7 mg/dl. IDH occurred in 15.6% of HD sessions. In the adjusted model, higher pre-HD serum phosphate (per 1 mg/dl) was associated with a 12% increased risk of IDH (aOR 1.12, 95% CI 1.10-1.13, p <0.001). In exploratory models where pre-HD laboratory values were available, the effect estimate was attenuated but remained statistically significant (aOR 1.05; 95% CI 1.02-1.08; p <0.01). Participants in the highest (compared with the lowest) quartile of pre-HD serum phosphate had a 56% greater risk of IDH in the adjusted model (aOR Q4:Q1 1.56; 95% CI 1.44-1.68, p <0.001). The association of higher phosphate with IDH was consistent in the HEMO data.

Discussion: Higher pre-HD serum phosphate is independently associated with an increased risk of IDH. As HD may cause an acute decline in serum phosphate, future studies to investigate the mechanisms of this association are warranted.

Keywords: blood pressure; end-stage kidney disease; hemodialysis; hypotension; intradialytic hypotension; phosphate.

PubMed Disclaimer

References

REFERENCES

    1. Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol: JASN. 2015;26:724-34.
    1. Reeves PB, Mc Causland FR. Mechanisms, clinical implications, and treatment of intradialytic hypotension. Clin J Am Soc Nephrol: CJASN. 2018;13:1297-303.
    1. Mc Causland FR, Tumlin JA, Roy-Chaudhury P, Koplan BA, Costea AI, Kher V, et al. Intradialytic hypotension and cardiac arrhythmias in patients undergoing maintenance hemodialysis: results from the monitoring in dialysis study. Clin J Am Soc Nephrol: CJASN. 2020;15:805-12.
    1. Sentveld B, van den Brink M, Brulez HF, Potter van Loon BJ, Weijmer MC, Siegert CE. The influence of blood volume-controlled ultrafiltration on hemodynamic stability and quality of life. Hemodialysis. 2008;12:39-44.
    1. Krasniak A, Drozdz M, Pasowicz M, et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol, Dial, Transplant. 2007;22:515-21.

Publication types